152 related articles for article (PubMed ID: 22201674)
1. IL-1 and atherosclerosis: a murine twist to an evolving human story.
Rader DJ
J Clin Invest; 2012 Jan; 122(1):27-30. PubMed ID: 22201674
[TBL] [Abstract][Full Text] [Related]
2. Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice.
Alexander MR; Moehle CW; Johnson JL; Yang Z; Lee JK; Jackson CL; Owens GK
J Clin Invest; 2012 Jan; 122(1):70-9. PubMed ID: 22201681
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound Biomicroscopic Imaging for Interleukin-1 Receptor Antagonist-Inhibiting Atherosclerosis and Markers of Inflammation in Atherosclerotic Development in Apolipoprotein-E Knockout Mice.
Li RJ; Sun Y; Wang Q; Yang J; Yang Y; Song L; Wang Z; Luo XH; Su RJ
Tex Heart Inst J; 2015 Aug; 42(4):319-26. PubMed ID: 26413013
[TBL] [Abstract][Full Text] [Related]
4. Transgenic Overexpression of IL-37 Protects Against Atherosclerosis and Strengthens Plaque Stability.
Liu J; Lin J; He S; Wu C; Wang B; Liu J; Duan Y; Liu T; Shan S; Yang K; Dong N; Ji Q; Huang K; Li D
Cell Physiol Biochem; 2018; 45(3):1034-1050. PubMed ID: 29439249
[TBL] [Abstract][Full Text] [Related]
5. Exogenous interleukin 37 ameliorates atherosclerosis via inducing the Treg response in ApoE-deficient mice.
Ji Q; Meng K; Yu K; Huang S; Huang Y; Min X; Zhong Y; Wu B; Liu Y; Nie S; Zhang J; Zhou Y; Zeng Q
Sci Rep; 2017 Jun; 7(1):3310. PubMed ID: 28607385
[TBL] [Abstract][Full Text] [Related]
6. CCR5 facilitates endothelial progenitor cell recruitment and promotes the stabilization of atherosclerotic plaques in ApoE-/- mice.
Zhang Z; Dong J; Lobe CG; Gong P; Liu J; Liao L
Stem Cell Res Ther; 2015 Mar; 6(1):36. PubMed ID: 25889019
[TBL] [Abstract][Full Text] [Related]
7. The potential role of IL-37 in atherosclerosis.
Wu BW; Zeng QT; Meng K; Ji QW
Pharmazie; 2013 Nov; 68(11):857-60. PubMed ID: 24380232
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-33 induces expression of adhesion molecules and inflammatory activation in human endothelial cells and in human atherosclerotic plaques.
Demyanets S; Konya V; Kastl SP; Kaun C; Rauscher S; Niessner A; Pentz R; Pfaffenberger S; Rychli K; Lemberger CE; de Martin R; Heinemann A; Huk I; Gröger M; Maurer G; Huber K; Wojta J
Arterioscler Thromb Vasc Biol; 2011 Sep; 31(9):2080-9. PubMed ID: 21737781
[TBL] [Abstract][Full Text] [Related]
9. IL-19 Halts Progression of Atherosclerotic Plaque, Polarizes, and Increases Cholesterol Uptake and Efflux in Macrophages.
Gabunia K; Ellison S; Kelemen S; Kako F; Cornwell WD; Rogers TJ; Datta PK; Ouimet M; Moore KJ; Autieri MV
Am J Pathol; 2016 May; 186(5):1361-74. PubMed ID: 26952642
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR
Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications.
Chi H; Messas E; Levine RA; Graves DT; Amar S
Circulation; 2004 Sep; 110(12):1678-85. PubMed ID: 15353494
[TBL] [Abstract][Full Text] [Related]
12. Metalloproteinases and advanced glycation end products: coupled navigation in atherosclerotic plaque pathophysiology?
Furfaro AL; Sanguineti R; Storace D; Monacelli F; Puzzo A; Pronzato MA; Odetti P; Traverso N
Exp Clin Endocrinol Diabetes; 2012 Nov; 120(10):586-90. PubMed ID: 23073918
[TBL] [Abstract][Full Text] [Related]
13. IL-33/IL-33R in various types of carotid artery atherosclerotic lesions.
Stankovic M; Ljujic B; Babic S; Maravic-Stojkovic V; Mitrovic S; Arsenijevic N; Radak D; Pejnovic N; Lukic ML
Cytokine; 2019 Aug; 120():242-250. PubMed ID: 31132589
[TBL] [Abstract][Full Text] [Related]
14. Deleting myeloid IL-10 receptor signalling attenuates atherosclerosis in LDLR-/- mice by altering intestinal cholesterol fluxes.
Stöger JL; Boshuizen MC; Brufau G; Gijbels MJ; Wolfs IM; van der Velden S; Pöttgens CC; Vergouwe MN; Wijnands E; Beckers L; Goossens P; Kerksiek A; Havinga R; Müller W; Lütjohann D; Groen AK; de Winther MP
Thromb Haemost; 2016 Aug; 116(3):565-77. PubMed ID: 27358035
[TBL] [Abstract][Full Text] [Related]
15. Liraglutide Attenuates Preestablished Atherosclerosis in Apolipoprotein E-Deficient Mice via Regulation of Immune Cell Phenotypes and Proinflammatory Mediators.
Bruen R; Curley S; Kajani S; Lynch G; O'Reilly ME; Dillon ET; Brennan EP; Barry M; Sheehan S; McGillicuddy FC; Belton O
J Pharmacol Exp Ther; 2019 Sep; 370(3):447-458. PubMed ID: 31270216
[TBL] [Abstract][Full Text] [Related]
16. Skin-Derived Mesenchymal Stem Cells Alleviate Atherosclerosis via Modulating Macrophage Function.
Li Q; Sun W; Wang X; Zhang K; Xi W; Gao P
Stem Cells Transl Med; 2015 Nov; 4(11):1294-301. PubMed ID: 26400926
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice.
Bhaskar V; Yin J; Mirza AM; Phan D; Vanegas S; Issafras H; Michelson K; Hunter JJ; Kantak SS
Atherosclerosis; 2011 Jun; 216(2):313-20. PubMed ID: 21411094
[TBL] [Abstract][Full Text] [Related]
18. Augmented Th17 differentiation in Trim21 deficiency promotes a stable phenotype of atherosclerotic plaques with high collagen content.
Brauner S; Jiang X; Thorlacius GE; Lundberg AM; Östberg T; Yan ZQ; Kuchroo VK; Hansson GK; Wahren-Herlenius M
Cardiovasc Res; 2018 Jan; 114(1):158-167. PubMed ID: 29016728
[TBL] [Abstract][Full Text] [Related]
19. Histone Deacetylase 9 Activates IKK to Regulate Atherosclerotic Plaque Vulnerability.
Asare Y; Campbell-James TA; Bokov Y; Yu LL; Prestel M; El Bounkari O; Roth S; Megens RTA; Straub T; Thomas K; Yan G; Schneider M; Ziesch N; Tiedt S; Silvestre-Roig C; Braster Q; Huang Y; Schneider M; Malik R; Haffner C; Liesz A; Soehnlein O; Bernhagen J; Dichgans M
Circ Res; 2020 Aug; 127(6):811-823. PubMed ID: 32546048
[TBL] [Abstract][Full Text] [Related]
20. Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice.
Kirii H; Niwa T; Yamada Y; Wada H; Saito K; Iwakura Y; Asano M; Moriwaki H; Seishima M
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):656-60. PubMed ID: 12615675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
